Lederer & Associates Investment Counsel Abb Vie Inc. Transaction History

Lederer & Associates Investment Counsel

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$65.7 - $83.98 $922,756 - $1.18 Million	-14,045 Closed	0 $0
Q1 2019 Apr 12, 2019	BUY	$77.14 - $90.79 $576,235 - $678,201	7,470 Added 113.61%	14,045 $1.13 Million
Q4 2018 Jan 25, 2019	SELL	$77.85 - $96.01 $484,226 - $597,182	-6,220 Reduced 48.61%	6,575 $606,000
Q3 2018 Oct 22, 2018	BUY	$88.91 - $98.84 $43,121 - $47,937	485 Added 3.94%	12,795 $1.21 Million
Q2 2018 Jul 27, 2018	SELL	$89.78 - $106.23 $1,346 - $1,593	-15 Reduced 0.12%	12,310 $1.14 Million
Q1 2018 Apr 09, 2018	BUY	$92.01 - $123.21 $1.13 Million - $1.52 Million	12,325 New	12,325 $1.17 Million

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Lederer & Associates Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Lederer & Associates Investment Counsel with notifications on news.